FHIR IG analytics19,234 resources
Start Prev Rows 9400 - 9600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date |
|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2425.json | Conjunctival Suffusion (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2426.json | Leptospira species (Tests by Microscopic Observation) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2427.json | Leptospirosis (Tests for Leptospira Antibody by Agglutination) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2428.json | Leptospirosis (Tests for Leptospira Antibody by Indirect Immunofluorescence) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2429.json | Conjunctival Suffusion (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2430.json | Pleural effusion (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2431.json | Pleural effusion (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2432.json | Abdominal swelling (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2433.json | Abdominal swelling (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2434.json | Neck swelling (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2435.json | Neck swelling (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2436.json | Diaphoresis (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2437.json | Diaphoresis (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2438.json | Edema (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2439.json | Edema (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.244.json | Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2440.json | Anthrax (Tests for Bacillus anthracis Protective Antigen Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2441.json | Anthrax (Tests for Bacillus species by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2442.json | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2443.json | Influenza A (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2444.json | Influenza B (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2445.json | Influenza [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2446.json | Influenza A (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2447.json | Influenza [Unspecified] (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2448.json | Influenza (Tests for unspecified influenza virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2449.json | Influenza (Tests for influenza B virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2450.json | Influenza (Tests for unspecified influenza virus Antigen) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2451.json | Influenza (Tests for influenza B virus Antigen) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2452.json | Influenza (unspecified influenza virus in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2453.json | Influenza (influenza B virus in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2454.json | Influenza (Tests for unspecified influenza virus by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2455.json | Influenza (Tests for influenza B virus by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2456.json | Hepatitis B Virus Infection (Tests for Hepatitis B Virus Total Core Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2457.json | Hepatitis C Virus Infection (Combination Tests that include hepatitis C virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2458.json | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2459.json | Louseborne relapsing fever (Tests for Borrelia recurrentis Nucleic Acid in Blood) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2460.json | Borrelia species (Tests by Microscopic Observation) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2461.json | Borrelia species (Tests by Microscopic Observation in Blood) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2462.json | Spirochetes (Tests by Microscopic Observation) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2463.json | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2464.json | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2465.json | CRE (Tests for Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2466.json | CRE (Tests for Proteus spp., Providencia spp., and Morganella spp. by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2467.json | CRE (Tests for Enterobacterales species Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2468.json | CRE (Combination Tests that include Enterobacterales by Culture and Identification) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2469.json | Tests for Carbapenem Susceptibility [Meropenem and Doripenem] | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2470.json | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2471.json | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2473.json | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2474.json | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2475.json | Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2476.json | Aortic valve stenosis (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2477.json | Anotia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2478.json | Microtia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2479.json | Microtia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2480.json | Anotia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2482.json | Anophthalmia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2483.json | Anophthalmia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2484.json | Microphthalmia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2485.json | Microphthalmia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2486.json | Atrial septal defect (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2487.json | Atrial septal defect (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2488.json | Fetal Aortic valve stenosis (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2489.json | Congenital Posterior Urethral Valves (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2490.json | Congenital Posterior Urethral Valves (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2491.json | Bladder Exstrophy (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2492.json | Bladder Exstrophy (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2493.json | Encephalocele (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2494.json | Fetal Encephalocele (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2495.json | Encephalocele (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2496.json | Choanal Atresia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2497.json | Choanal Atresia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2498.json | Cloacal Exstrophy (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2499.json | Cloacal Exstrophy (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2500.json | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2501.json | Renal Agenesis or Hypoplasia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2502.json | Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2503.json | Trisomy 13 (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2504.json | Fetal Trisomy 13 (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2505.json | Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2506.json | Galactosemia (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2507.json | Galactosemia (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2508.json | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2509.json | Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2510.json | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2511.json | Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative]) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2512.json | Galactosemia (Tests for Galactokinase (GALK) [Quantitative]) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2513.json | Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative]) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2514.json | Galactosemia (Tests for GALT gene allele 1) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2515.json | Galactosemia (Tests for GALT gene allele 2) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2516.json | Hypospadias (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2517.json | Hypospadias (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2518.json | Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2519.json | Fetal Trisomy 18 (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2520.json | Fetal Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2521.json | Trisomy 18 (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2522.json | Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2523.json | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2524.json | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2525.json | Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2526.json | Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2527.json | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2528.json | Ventricular septal defect (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2529.json | Ventricular septal defect (Disorders) (ICD10CM) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2530.json | Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2531.json | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2532.json | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.2533.json | Congenital Cytomegalovirus (Tests for CMV Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.268.json | Mumps (Tests for mumps virus IgM Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.272.json | Present or Positive Lab Result Value | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.282.json | Varicella (Tests for Varicella zoster virus by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.283.json | Varicella (Tests for Varicella zoster virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.285.json | Encephalitis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.287.json | Varicella (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.289.json | Carbon Monoxide Poisoning (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.293.json | Toxic Effects of Lead (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.297.json | Measles (Tests for measles virus Nucleic Acid) | active | 2025-03 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.299.json | Measles (Tests for measles virus IgM Antibody) | active | 2025-03 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.300.json | Meningococcal Disease (Organism or Substance in Lab Results) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.301.json | Shigellosis (Tests for Shigella species by Culture and Identification Method) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.307.json | Leptospirosis (Tests for Leptospira IgM Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.308.json | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.310.json | Bacteria (Tests by Culture and Identification Method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.311.json | Viruses (Tests by Culture and Identification Method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.316.json | Rubella (Tests for rubella virus IgM Antibody) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.317.json | Shigellosis (Tests for Shigella species Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.319.json | Fungi (Tests by Culture and Identification Method) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.322.json | Pesticide Related Illness (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.329.json | Apnea (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.330.json | Apnea (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.333.json | Shigellosis (Organism or Substance in Lab Results) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.335.json | Influenza (Tests for influenza A virus by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.336.json | Influenza (Tests for influenza A or B virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.340.json | Influenza (influenza A or B virus in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.341.json | Campylobacteriosis (Organism or Substance in Lab Results) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.342.json | Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.343.json | Campylobacteriosis (Tests for Campylobacter species Nucleic Acid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.344.json | Campylobacteriosis (Tests for Campylobacter species Antigen) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.349.json | Hepatitis A (Tests for hepatitis A virus IgM Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.353.json | Diarrhea (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.356.json | HIV Infection (Organism or Substance in Lab Results) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.359.json | Botulism (Disorders) (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.362.json | Hansen’s Disease (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.365.json | Silicosis (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.366.json | Silicosis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.371.json | Cryptosporidiosis (Organism or Substance in Lab Results) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.372.json | Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.375.json | Cyclosporiasis (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.376.json | Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.379.json | Giardiasis (Tests for Giardia species Nucleic Acid) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.384.json | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.386.json | Vibriosis (Organism or Substance in Lab Results) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.388.json | Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.390.json | Trichinellosis (Tests for Trichinella species Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.395.json | Syphilis (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.396.json | Syphilis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.398.json | Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.399.json | Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.40.json | STEC Infection (Disorders) (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.400.json | Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.401.json | Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.403.json | Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.405.json | Hantavirus Infection and Diseases (Disorders) (ICD10CM) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.407.json | Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.408.json | Hepatitis B Virus Infection (Organism or Substance in Lab Results) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.422.json | Tuberculosis (Disorders) (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.427.json | STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.43.json | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.436.json | Coccidioidomycosis (Tests for Coccidioides species IgM Antibody) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.437.json | Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.438.json | Coccidioidomycosis (Tests for Coccidioides species Antigen) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.44.json | Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.445.json | Legionellosis (Tests for Legionella species Antigen) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.446.json | Legionellosis (Tests for Legionella species Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.451.json | Tuberculosis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.460.json | HIV Infection or AIDS (Disorders) (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.464.json | Malaria (Tests for Plasmodium species Nucleic Acid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.468.json | Leptospirosis (Tests for Leptospira Nucleic Acid) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.471.json | Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.472.json | Leptospirosis (Tests for Leptospira Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.476.json | Babesia species (Tests by Microscopic Observation in Blood) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.478.json | Anthrax (Tests for Bacillus anthracis by Culture and Identification Method) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.479.json | Anthrax (Tests for Bacillus anthracis Nucleic Acid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.48.json | Salmonellosis (Disorders) (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.480.json | Anthrax (Tests for Bacillus anthracis Antigen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.481.json | Anthrax (Tests for Bacillus anthracis Antibody) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.494.json | Ehrlichiosis (Organism or Substance in Lab Results) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.496.json | Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen]) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.500.json | Q Fever (Tests for Coxiella burnetii Nucleic Acid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.505.json | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.507.json | Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.512.json | Brucellosis (Tests for Brucella species Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.515.json | Brucellosis (Tests for Brucella species Antibody [Quantitative]) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.516.json | Brucellosis (Organism or Substance in Lab Results) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.519.json | Dengue Virus Infection (Tests for dengue virus Nucleic Acid) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.523.json | Dengue Virus Infection (Tests for dengue virus Antigen) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.524.json | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative]) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.525.json | Dengue Virus Infection (Tests for dengue virus IgM Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.527.json | Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative]) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.530.json | Borrelia species (Tests for Nucleic Acid) | active | 2024-01 |
FHIR
FHIRsmith